We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SARS-CoV-2 Neutralizing Antibody Research and Development

SARS-CoV-2 Neutralizing Antibody Research and Development content piece image

In response to the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers across the globe have united in efforts to develop effective therapeutic and preventive strategies against the virus.

Neutralizing antibodies are currently being investigated as one such strategy against SARS-CoV-2, as they have the potential to block the virus from infecting host cells.

Download this whitepaper to learn more about:

  • The antiviral mechanism of SARS-CoV-2 neutralizing antibodies
  • Global efforts to develop neutralizing antibody products against SARS-CoV-2
  • Mutated SARS-CoV-2 and it’s impact on the protective ability of neutralizing antibodies